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A b s t r a c t
The aim of the study was a retrospective analysis of the frequency of group B streptococci (Streptococcus agalactaie; GBS) carriage in 
pregnant women from the region of Krakow, together with an analysis of their drug resistance, carried out between 2008-2012. The study 
included 3363 pregnant women between 35 and 37 weeks of gestation, studied in accordance with the guidelines of the Polish Gynecologi­
cal Society (2008). A high percentage of pregnant women who are carriers of group B streptococci was demonstrated. Each year covered 
by the study, it was in the range of 25-30%, with an average value equal to 28%. The results confirm the need for taking swabs from both 
the vagina and anus, since 15% of GBS-positive patients showed only rectal carriage. High percentage of isolates resistant to erythromycin 
was detected, which ranged from 22% to 29%, with an average value equal to 25%, as well as a high proportion of isolates resistant to 
clindamycin being 17-25%, with an average of 20%. The results indicate the need to standardize the methodology of collecting samples for 
GBS testing and introduce microbiological diagnostic standards in all gynecological and obstetric centers in Poland, in order to carry out 
a detailed epidemiological analysis in our country.
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Beta-hemolytic Group B Streptococci (GBS), rep­
resented by Streptococcus agalactiae, were the main 
etiological factor for neonatal infections in the USA in 
the 1970s. These infections usually appear in the form 
of Early Onset Disease (EOD), which develops in the 
first seven days of life with clinical manifestations of 
sepsis and mortality reaching 50%, or in the form of 
Late Onset Disease (LOD), which develops between 
the 7th and 90th day of life and usually takes the form 
of meningitis (Schrag etal, 2002; Verani etal, 2010).
The recorded rapid growth of the number of GBS 
infections in newborns was the reason behind devising 
guidelines aimed at newborn infections prevention by 
the American College of Obstetrics and Gynecology 
(ACOG) and Centers for Disease Control and Preven­
tion (CDC) in 1996, and a year later by the American 
Academy of Pediatrics (AAP). CDC recommendations 
were updated for the first time in 2001 and published in 
2002 (Schrag etal., 2002), and also subsequently sub­
jected to evaluation and published once again in 2010 
(Verani etal., 2010). Following the example of Ameri­
can scientists, many member countries of the European
Union have introduced their own guidelines with the 
goal of preventing GBS infections in newborns. These 
include: Italy in 1996, Spain in 1998 and 2003, France in 
2001, Germany in 1996 and 2008, Great Britain in 2003, 
Belgium in 2003, Switzerland in 2007 and the Czech 
Republic in 2008 (Rodriguez-Granger etal, 2012). In 
2008, under the patronage of the Polish Gynecologi­
cal Society (PTG), a Polish version of the recommen­
dations was devised concerning the detailed instruc­
tions in the prophylaxis of GBS infections in newborns 
(Kotarski etal, 2008).
The acquired experiences indicate that the most 
effective method of limiting the number of infections 
in newborns is the introduction of screening of all preg­
nant women for GBS carriage and, should a positive 
result be obtained, implementing targeted perinatal anti­
biotic prophylaxis. It is a well-known fact that the most 
significant factor predisposing newborns to the develop­
ment of infection is the presence of S. agalactiae in their 
mother’s genital or gastrointestinal tract, from where 
the bacteria are transmitted to the baby. Therefore, it 
is advised to carry out microbiological examination of
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the vagina and anus in women between the 35th and 
37th week of pregnancy. As GBS colonization is often 
transitory, predicting on the grounds of a culture per­
formed earlier than 5 weeks before delivery is fallible 
and recommended only in special cases, i.a. in women 
with a threat of premature labor or with premature rup­
ture of membranes (PROM). If there is no test result for 
GBS carriage, the doctor should administer intrapar­
tum chemoprophylaxis to a pregnant woman who has 
been diagnosed with at least one of the following risk 
factors of early onset disease: premature labor or PROM 
(before the 37th week of gestation); delivery at term, in 
which over 18 hours have passed since the rupture of 
membranes; developing fever of over 38°C for unknown 
reasons during delivery; developing urinary tract infec­
tion or bacteriuria caused by GBS during the course of 
the pregnancy; history of delivering a child, who was dia­
gnosed with an infection of S. agalactiae etiology (Kotar- 
ski etal, 2008; Schrag et a l, 2002; Verani et al., 2010).
In Europe, GBS colonization of pregnant women 
amounts to, according to literature data, from 6.6% in 
Greece (Tsolia etal, 2003), 7% in Spain (Bayo etal, 
2002), 14% in Great Britain (Colbur etal, 2007), 16% in 
Germany (Brimil etal, 2006), 30% in the Czech Repub­
lic (Motlova etal, 2004) to 36% in Denmark (Hansen 
et al., 2004). In Poland, the percentage of GBS carriage 
in pregnant women, which is usually presented, differs 
significantly depending on the examined patient popu­
lation and the employed method and comes to 4.3% 
in Lublin (Stupak etal, 2010), 5.13% in Lodz (Serafin 
etal, 2010), 11.4% in Warsaw (Kociszewska-Najman 
etal, 2010), 19% in Rzeszow (Krasnianin etal, 2008), 
27.8% in Katowice (Romanik etal, 2011) and 30% in 
Krakow (Brzychczy-Wloch etal, 2012).
Getting to know the frequency of GBS carriage in 
pregnant women in various populations in Poland and 
the analysis of their drug resistance, observed over 
time, is of significant importance in epidemiological 
research and also in estimating the group of patients 
requiring the implementation of suitable antibiotic 
prophylaxis. Unfortunately, Poland is still lacking in 
sufficient data obtained with the use of uniform stand­
ards of microbiological examination assessing the fre­
quency of GBS occurrence among pregnant women and 
their drug resistance. Furthermore, there is a lack of 
analyses depicting the dynamics of changes in carriage 
and drug resistance of S. agalactiae over the period of 
several years of research.
The objective of the work concerned a retrospective 
analysis of the frequency of GBS (Streptococcus agalac­
tiae) carriage in pregnant women from the region of 
Krakow, as well as the analysis of their drug resistance, 
carried out in the years 2008-2012.
The testing of GBS carriage in pregnant women 
was conducted in the period of time from 1st Janu­
ary 2008 to 31st December 2012 on 3363 patients of 
the Rafal Czerwiakowski Na Siemiradzkiego Hospi­
tal in Krakow. The testing was carried out according 
to the PTG recommendations (Kotarski etal, 2008), 
upon prior acquisition of a positive opinion from the 
Bioethics Committee of the Jagiellonian University 
No. KBET/ 143/B/2007.
The research material was constituted by two sam­
ples taken from each pregnant woman with the use of 
separate cotton swabs, including a swab from the vagina 
taken without the use of a speculum and a swab from 
the anus taken after overcoming the sphincter resist­
ance. The materials were taken between the 35th and 
37th week of pregnancy, during a control visit to the 
gynecologist, and then, within 4 hours, delivered to 
the Microbiological Diagnostics Lab of the Jagiello­
nian University Medical College in Amies (bioMer- 
ieux) transport medium. Swabs were carried separately 
to Todd Hewitt Broth with the addition of gentamicin 
(8 pg/ml) and nalidixic acid (15 pg/ml) (Oxoid) and 
incubated for 18-24 h at 37°C in aerobic conditions. 
After preliminary pre-incubation, the materials were 
cultivated on Columbia Blood Agar (Difco) solid 
medium with the addition of 5% sheep blood and cul­
tured for 24 h at 37°C in aerobic conditions. S. agalac­
tiae species identification was carried out with the use 
of a SLIDEX STREPTO B (bioMerieux) latex agglutina­
tion test, CAMP test and API STREP (bioMerieux) test.
Drug resistance testing was performed for 1623 
S. agalactiae isolates obtained from all of the positive 
materials, from both vaginal and anal swabs. The study 
was performed with the Kirby-Bauer antibiotic testing 
method using antibiotic discs: penicillin (10IU), ampi- 
cillin (10 pg), clindamycin (2 pg), erythromycin (15 pg), 
nitrofurantoin (100 pg) and ofloxacin (5pg) (Oxoid). 
The results were interpreted according to EUCAST 
guidelines (EUCAST 2012). There were three mac- 
rolide-lincosamide-streptogramin B resistance pheno­
types determined for the S. agalactiae isolates, i.e. con­
stitutive MLSfl resistance phenotype -  cMLSfi, inducible 
MLSb resistance phenotype -  iMLSB, and M phenotype.
The analysis of GBS carriage by year, with particu­
lar attention to the materials, i.e. anal swabs, was con­
ducted by a x2 (chi-square) test. Meanwhile, the carriage 
in individual months was analyzed in two ways. The 
first one involved the employment of x2 test analysis; 
the second one, enabling more accurate investigations, 
consisted in conducting standardization of the fraction 
of GBS-positive patients for every month, in which the 
basis for standardization was determined by the average 
value and the standard deviation from the whole stud­
ied period. The dependence of standardized data on the 
months or seasons was tested using the analysis of vari­
ance and Student’s f-distribution test. Resistance trends 
in time were examined with the use of Pearsons regres­
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Fig. 1. Frequency of S. agalactiae carriage in the vagina, anus and both of them simultaneously in the years 2008-2012.
sion analysis. P  values of < 0.05 were considered sig­
nificant. Analyses were provided with package R 7.02.
In the analyzed period of five years (2008-2012), 
3363 pregnant women were included into the study 
of GBS carriage. They were between their 35th and 
37th week of gestation. The number of patients tested in 
2008 was 620 (18%), in 2009 -  771 (23%), in 2010 -  802 
(24%), in 2011 -  651 (19%), and in 2012 -  519 (16%). 
The studied group of patients was constituted by women 
between 18 and 44 years old with a average value age of 
30.5. Altogether, 6726 materials, in the form of vaginal 
and anal swabs collected in pairs from each patient, were 
subjected to microbiological diagnostics.
The percentage of S. agalactiae carriers, determined 
in the consecutive years of the study, is presented in 
Figure 1. The place of isolation of streptococci, being 
either vagina, anus, or both simultaneously, is included. 
The obtained results point to a high percentage of GBS- 
colonized pregnant women and remained at a compara­
ble level throughout the subsequent years. GBS carriage 
in the subsequent years was: in 2008 -  30% (184/620), 
in 2009 -  30% (233/771), in 2010 -  25% (202/802), in 
2011 -  25% (189/651), and in 2012 -  28% (145/519), 
with the average value for the five-year period of the 
study reaching 28% (953/3363). It was demonstrated 
that the year of the study had no significant impact 
on the frequency of GBS carriage in pregnant women 
(X2 = 6.010;p = 0.1984).
The presence of S. agalactiae simultaneously in the 
vagina and anus was determined in 20% (670/3363) of 
women included into the study, which constituted 70% 
(670/953) of patients in comparison with the number of 
GBS-positive patients. The obtained results confirm the 
necessity to take anal swabs, as in 4% (147/3363) of the
patients out of all of the pregnant women included into 
the research, GBS carriage was only present in anus, 
which constituted 15% among all the patients who were 
GBS carriers (147/953). On the basis of statistical analy­
sis, a significantly higher detection of GBS carriage was 
demonstrated by taking into consideration the material, 
i.e. anal swabs (x2 = 16.365; p <  0.0001). Additionally, 
GBS carriage only in the vagina has been confirmed 
in 4% (136/3363) of patients, which constitutes 14% 
(136/953) in the group of GBS-positive patients.
The frequency of S. agalactiae carriage in individual 
months of the year that was analyzed over the period 
of 5 years encompassed by the research was presented 
in Figure 2. In selected cases, high divergence of results 
was obtained for individual months. It can be exempli­
fied by two extreme values; the former being 15% (9/58) 
of patients colonized with GBS in May 2010 and over 
a threefold increase in the percentage of GBS-positive 
patients of 47% (35/47) in August 2009 (data not pre­
sented). The average percentage of carriage determined 
for individual months of the year amounted to: in Janu­
ary -  31%, February -  30%, March -  31%, April -  27%, 
May -  27%, June -  27%, July -  25%, August -  31%, 
September -  29%, October -  23%, November -  27%, 
December -  31%. In order to demonstrate whether 
there is a relationship between GBS carriage and the 
individual months, patient attendance was compared 
in the months encompassed by the research. No signifi­
cant differences in GBS carriage were found while com­
paring individual months (x2 = 7.721;p = 0.7380). Simi­
larly, the analysis of a relationship between the months 
and the standardized frequency of GBS carriage did 
not show statistical significance (f=  0.7141;p = 0.7190). 
However, since there were very many categories of
430 Brzychczy-Wloch M. et al 4
January February March April May June July August September October November December
the individual months in the studied years 2008-2012 
Fig. 2. The average frequency of S. agalactiae carriage in individual months in the years 2008-2012.
explanatory variables (months) in the analyzed sample 
with a relatively small number of measurements (years), 
showing such a significance is extremely difficult. For 
this reason, a generalization of the quantitative variable 
was performed changing it to seasons, what made it 
possible to demonstrate a difference on the border of 
statistical significance (t= 1.940835; p = 0.0572). After 
removing the outlier, being August 2009 (data not 
shown), the observed difference was statistically signifi­
cant for winter (the period from December to March), 
where the frequency of carriage was higher than with 
the other months of the year (t=2.163241; p =  0.0348).
While analyzing drug resistance, it was determined 
that all the S. agalactiae strains isolated in the period 
of five years encompassed by the study were sensitive 
to penicillin, ampicillin, nitrofurantoin, and ofloxa­
cin. In the years 2008-2012, in the studied group of 
patients, the percentage of strains resistant to erythro­
mycin was 7% (234/3363), while to clindamycin it was 
6% (191/3363). Taking into the account the group 
of GBS-positive patients, the percentage of strains 
resistant to erythromycin in the years 2008-2012 
reached 25% (234/953), in 2008 -  24% (45/184), in 
2009 -  22% (51/233), in 2010 -  24% (49/202), in 2011 
-  25% (46/189), and in 2012 -  29% (42/145). Similarly, 
in the case of clindamycin, the percentage of resistant 
strains in the years 2008-2012 was 20% (191/953), in 
2008 -  21% (39/184), 2009 -  17% (39/233), 2010 -  19% 
(39/202), 2011 -  20% (38/189) and in 2012 -  25% 
(36/145). In the period of five years encompassed by 
the study, a resistance trend was determined showing 
statistically insignificant trend increase (R2 = 0.4653; 
f=  2.6115; p = 0.2045). It should be emphasized, though, 
that the time series involving only five years is incred­
ibly susceptible to artifacts, so obtaining a fully reliable 
trend assessment would require a long time for analysis.
The percentage of isolates resistant to macrolides and 
the share of particular resistance phenotypes in the years 
encompassed by the research were presented in Figure 3. 
Among resistant isolates, in the years 2008-2012, the 
domineering one was the constitutive resistance pheno­
type for macrolides, lincosamides and streptogramins B 
(cMLSb), constituting 82% (191/234) among all of the 
resistant GBS isolates, followed by M phenotype 11% 
(26/234) and inducible phenotype (iMLS0) 7% (17/234).
In 2008, under the patronage of the Polish Gyneco­
logical Society (PTG) and on the basis of the CDC rec­
ommendations from 2002 (Schrag et al, 2002), a Polish 
version of the recommendations was devised concern­
ing the detailed recommendations in the prophylaxis of 
GBS infections in newborns. In accordance with those, 
a test for GBS carriage in vagina and anus should be 
performed in pregnant women between the 35th and 
37th week of pregnancy (Kotarski etal, 2008). Accord­
ing to the regulation of the Polish Minister of Health 
from 23rd September 2010 specifying the standards 
of conduct and medical procedures which accom­
pany providing health services in perinatal care over 
a woman in the period of her philological pregnancy, 
childbirth, puerperium, and care over the newborn, it 
is recommended to perform vaginal vestibule and anal 
cultures for beta-hemolytic streptococci in all pregnant 
women between their 33rd and 37th week of pregnancy 
within the framework of the recommended range of 
prophylactic services and operations being part of 
health promoting services, diagnostic tests, and medi­
cal consultations (The regulation of the Polish Minister 
of Health from 23rd September 2010).
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Fig. 3. Percentage of S. agalactiae strains with cMLSB, iMLSB and M resistance phenotypes in the years 2008-2012.
In November 2010, on the basis of the latest epi­
demiological data and the opinions of experts, CDC 
together with ACOG and AAP, and also with the Amer­
ican College of Nurse-Midwives, American Academy 
of Family Physicians as well as American Society for 
Microbiology, updated the guidelines from 2002 con­
cerning preventing GBS infections in newborns. The 
most significant changes pertain to: (1) Expanding 
laboratory methods serving increasing the sensitivity 
of determining GBS in the studied materials by the 
employment of chromogenic culture media and the 
use of commercially-available tests based on nucleic 
acids amplification. (2) The introduction of screening 
of pregnant women for determining bacteriuria and 
establishing the threshold number of GBS amounting 
to > 104 cfu (colony forming units) for 1 ml urine sam­
ple, for which the culture result is deemed positive. (3) 
Verification of conduct algorithm in the case of women 
with a threat of premature delivery or premature rup­
ture of fetal membranes. (4) Defining the notion of 
suitable perinatal antibiotic prophylaxis, which consists 
in the employment of penicillin (changes in dosage), 
ampicillin or, additionally, cefazolin at least four hours 
before labor. (5) The notion of high risk of anaphylaxis 
was defined and, because of the high percentage of 
strains resistant to macrolides, erythromycin was with­
drawn from perinatal prophylaxis. (6) In addition, the 
algorithm of conduct with a small newborn threatened 
with early onset disease (EOD) underwent modifica­
tion (Verani etal, 2010).
By the employment of PTG recommendations from 
2008 concerning the diagnostics of pregnant women for 
group B streptococci, a high percentage of S. agalactiae
colonization of pregnant women was confirmed on the 
basis of the obtained results. The number, in the indi­
vidual years encompassed by the study (2008-2012), 
ranged from 25% to 30%, with the average value of 28%. 
This result brings Poland closer to the countries with the 
highest percentage of GBS colonization among preg­
nant women that is described in literature, i.e. Slovakia 
with 30% (Motlova et a l, 2004) and Denmark with 36% 
(Hansen etal, 2004). In comparison with our previous 
research, from the years 2004-2006, in which carriage, 
depending on the applied method, was estimated to 
range between 13% and 17% (Strus etal, 2009) and 
from the years 2007-2009, in which the participation of 
GBS-positive patients reached 30% (Brzychczy-Wloch 
etal, 2012). The current result points to a lingering 
high percentage of colonized pregnant women resid­
ing in the region of Krakow. The observed higher inci­
dence of carriage was most probably connected with 
the increase in sensitivity of the diagnostic methods 
and the introduction of standardized microbiological 
procedures. Hansen etal, 2004, reached similar results 
upon the introduction of a new differential medium, by 
which the sensitivity of GBS detection was increased 
from 15% to 36% (Hansen etal, 2004). The detected 
high percentage of GBS colonization in the studied 
group of patients differs significantly from the results 
obtained by researchers from other centers in our coun­
try. For instance, the research of the Warsaw center 
carried out in the years 2007-2008 recorded GBS col­
onization in 11.4% of pregnant women (Kociszewska- 
Najman etal, 2010); similarly, the results of the Lodz 
center from 2008 indicate only 5.13% carriage in that 
patient population (Serafin etal, 2010) and the research
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performed in 2008 by the Lublin center, in which GBS 
carriage was demonstrated only in 4.3% of women 
(Stupak etal, 2010). The low percentage of colonization 
described by the authors of the quoted studies might 
have been related to different geographical areas and 
methodology of the conducted research. For instance, 
in the research carried out in Lublin, the studied mate­
rial was constituted only by vaginal swabs and there 
is a lack of a description of culture methodology and 
diagnostics of group B streptococci (Stupak etal, 2010). 
Worth noting to the special resemblance of our results 
to the data coming from Katowice, where percentage 
of GBS colonization in pregnant women was 27.8% 
(Romanik etal, 2011).
It is worthwhile mentioning that the standardiza­
tion of microbiological diagnostics with the aim of 
determining GBS carriage in women is of fundamental 
importance in correct diagnostics of pregnant women. 
In accordance with CDC, the lack of preliminary mate­
rial preincubation in a selective medium decreases 
method sensitivity even by 50% (Schrag etal, 2002). 
Likewise, collecting swabs only from the vagina or only 
from the anus influences obtaining false-negative results 
in as many as 30% of patients (Brimil etal, 2006). The 
statistically significant results confirm the necessity to 
take anal swabs in parallel with vaginal swabs, as 15% 
of patients displayed carriage only in anus. Hence, the 
omission of the diagnostic material constituted by anal 
swabs has an impact on obtaining false-negative results 
in the amount of as much as 15%. Brimil etal, 2006, 
obtained similar results, which prove the fact that tak­
ing only vaginal swabs results in getting false-negative 
results in 24% of cases (Brimil etal, 2006). Summing up, 
according to the current PTG recommendations from 
2008, there are several factors significantly influenc­
ing a correct test result for GBS carriage, i.e. the type 
of material collected, it is required to be a vaginal and 
an anal swab, which, after their collection, can be put 
together into one test tube; employing appropriate trans­
port media, e.g. Amies medium; preliminary 18-24 h 
material preincubation, often skipped in many labs, 
which can be carried out, for example, on Todd Hewitt 
Broth with an addition of suitable antibiotics hamper­
ing the proliferation of other bacteria; isolation of all 
colonies characteristic of streptococci from the medium 
with blood, even the ones which do not possess beta 
hemolysis, since there is a small proportion of S. aga- 
lactiae strains that do not display this feature (Kotarski 
etal, 2008; Schrag etal, 2002; Verani etal, 2010).
A detailed analysis of the dynamics of change for 
individual months of the calendar year pointed to 
a statistically significant increase in carriage in winter 
months, in comparison to the remaining parts of the 
year. Ma etal, 2012, in the research concerning preg­
nant women from Taiwan, demonstrated an increase
in frequency of isolation of GBS strains representing 
hipervirulent ST-17 clone in winter months (Ma etal, 
2012). On the other hand, the study carried out by 
Dadvand etal, 2011, indicates a statistically signifi­
cant relation between the frequency of GBS carriage 
and August, the warmest and most humid month in 
Spain (Dadvand et a l, 2011). The obtained result is dif­
ficult to discuss as there are no publications describing 
analyses of this kind carried out on a similar sample 
group residing in a geographical area comparable as 
regards the climate.
Even though penicillins have been used for many 
years now, most of the S. agalactiae strains are still sen­
sitive to this antibiotic (Schrag etal, 2002; Verani etal, 
2010). However, the first strains of GBS with reduced 
penicillin susceptibility (PRGBS) were characterized in 
Japan (Kimura etal, 2008). Our research results con­
firm the sensitivity to penicillin and ampicillin for all 
of the GBS strains isolated in the period of five years 
encompassed by the study. However, in recent years, 
GBS strains’ resistance to macrolides, lincosamides and 
streptogramins B is more and more often described. 
Uh etal, 2005, demonstrated significant increase in 
the frequency of isolation of GBS strains resistant to 
erythromycin, from 0% in the 1990s to 41% in 2002, 
and to clindamycin, from 0% to 48% in the same peri­
ods (Uh etal, 2005). In Europe, the percentage of GBS 
strains resistant to erythromycin is from 11% in Ger­
many (Schoening etal, 2005), 14% in Spain (Gherardi 
etal, 2007), 16% in Italy (Gherardi etal, 2007), 21% in 
France (De Mouy etal, 2001), to 22% in Turkey (Acik- 
goz etal, 2004). The high percentage of S. agalactiae 
strains resistant to erythromycin reaching 25% and 
the high proportion of isolates resistant to clindamycin 
reaching 20%, were recorded by us, confirm the world­
wide tendencies, indicating increase in GBS drug resist­
ance. Two mechanisms are responsible for the resistance 
of streptococci to macrolides. The first one consists in 
active removal (pumping out) of the antibiotic from 
a bacterial cell. This mechanism is marked with pheno­
type M, coded by mef gene and determines resistance 
to 14- and 15-membered macrolides, i.e. erythromycin, 
clarithromycin, roxithromycin and azithromycin, but 
resistance to 16-membered macrolides, e.g. spiramy­
cin and clindamycin. The second type of resistance 
stems from methylation in place of the target activity 
in the ribosome and conditions the resistance to all 
the macrolides, lincosamides, and streptogramins B, 
which is described with MLSfi phenotype of constitu­
tive or of inducible character; however, clinically, it 
indicates a lack of effectiveness of all of those drugs 
(cross-resistance) (Acikgoz etal, 2004; Uh etal, 2005). 
In the isolate pool studied by our team, the constitutive 
phenotype was the dominant one (82%), followed by 
phenotype M (11%) and the inducible phenotype (7%),
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at the same time, the share of particular phenotypes was 
different in the individual years of the research.
To sum up, in the light of literature data from our 
country, often making use of different methods for 
diagnosing GBS from the recommended ones and also 
using the standards modified in 2010 by CDC, it is nec­
essary to consider an update of the 2008 PTG recom­
mendations and publishing them again, following the 
example of other countries, under the patronage of all 
of the Polish societies, directly related to the problem 
of newborn infection prophylaxis.
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